Cerebrolysin vs Semax
A broad-spectrum neurotrophic peptide mixture against a single, targeted BDNF-elevating heptapeptide. This comparison covers mechanisms, clinical research bases, and which fits which cognitive research goal.
Cerebrolysin
Porcine brain-derived neuropeptide preparation mimicking NGF, BDNF, and CNTF activity. Extensive European/Asian clinical base.
Shop Cerebrolysin →Semax
Synthetic ACTH 4-10-derived heptapeptide. Elevates BDNF and supports neuroplasticity with Phase 3 stroke-recovery trial data.
Shop Semax →Side-by-Side Comparison
| Factor | Cerebrolysin | Semax |
|---|---|---|
| Composition | Complex mixture of peptide fragments | Single defined heptapeptide |
| Origin | Porcine brain tissue extract | Synthetic, derived from ACTH 4-10 |
| Mimicked factors | NGF, BDNF, CNTF (multiple) | BDNF (primary target) |
| Clinical research base | Extensive — Europe/Asia, Alzheimer's, stroke, TBI | Extensive — Russia, Phase 3 stroke recovery data |
| Typical route | Intramuscular / subcutaneous | Intranasal or subcutaneous |
| Molecular profile | Complex — neuropeptide mixture | 813.9 Da, single molecule |
| Best for | Broad-spectrum neurotrophic support research | Targeted BDNF and neuroplasticity research |
Mechanism Deep Dive
Cerebrolysin — Broad Neurotrophic Mixture
Cerebrolysin contains a complex mixture of low-molecular-weight peptides and amino acids isolated from porcine brain tissue, exhibiting neurotrophic activity across multiple pathways simultaneously (NGF, BDNF, CNTF-like effects). Its small fragment sizes allow passive blood-brain barrier diffusion, and its clinical research base spans Alzheimer's disease, vascular dementia, stroke, and TBI recovery.
Shop Cerebrolysin →Semax — Targeted BDNF Elevation
Semax is a single, well-characterised molecule that elevates BDNF and supports neuronal plasticity through a defined mechanism derived from ACTH 4-10 research. Its Phase 3 clinical trial data for ischaemic stroke recovery and cognitive performance under stress makes it one of the best-studied single-molecule nootropic peptides.
Shop Semax →Which Peptide Wins For Each Goal?
Broad neurotrophic factor research
Cerebrolysin
Mimics multiple neurotrophic factors simultaneously rather than targeting a single pathway.
Targeted BDNF / neuroplasticity research
Semax
A single, well-defined molecule with a specific, well-characterised BDNF-elevating mechanism.
Ischaemic stroke recovery research
Both
Cerebrolysin and Semax both carry substantial clinical stroke-recovery research bases, through different mechanisms.
Cognitive performance under stress
Semax
Specifically studied for attention, focus, and performance enhancement under stress conditions.
Frequently Asked Questions
What is the difference between Cerebrolysin and Semax?
Cerebrolysin is a porcine brain-derived mixture of low-molecular-weight peptides mimicking multiple neurotrophic factors (NGF, BDNF, CNTF) at once. Semax is a single, precisely defined synthetic heptapeptide derived from ACTH 4-10 that specifically elevates BDNF. Cerebrolysin is a broad-spectrum neurotrophic mixture; Semax is a targeted single-molecule agent.
Which has more clinical research: Cerebrolysin or Semax?
Both have extensive research bases. Cerebrolysin has a large clinical literature in Europe and Asia covering Alzheimer's disease, stroke, and traumatic brain injury. Semax has Phase 3 clinical trial data specifically for ischaemic stroke recovery in Russian medical settings, alongside cognitive performance research.
Can Cerebrolysin and Semax be researched together?
Yes. Because Cerebrolysin provides a broad mixture of neurotrophic peptide fragments while Semax specifically drives BDNF elevation and neuroplasticity, some research protocols study them together to compare broad-spectrum vs targeted neurotrophic support.
Research use only. All products sold by JA Performance are strictly for laboratory and in vitro research purposes. Not for human consumption, medical use, or veterinary use.